Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4144 in Sepsis-associated Acute Kidney Injury (SERENIA)
NCT07215702Phase 2Recruiting
- Sponsor
- AstraZeneca
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of AZD4144 in acute kidney injury (AKI), sponsored by AstraZeneca. Started Feb 2026; status: recruiting.
02
Drugs
AZD4144
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07215702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07215702.